Search ( 33565 results )
- report/summary
(Updated on )
Monitoring of Antibiotic and Antifungal Use and Bacterial Resistance in Healthcare Facilities. SPARES Project. 2024 Results
The monitoring of antibiotic use and bacterial resistance to antibiotics in healthcare facilities (HCFs), a task entrusted to the SPARES initiative since 2018, contributes to the...
- report/summary
(Updated on )
Surveillance of bacterial antibiotic resistance in community care settings and nursing homes. PRIMO Project. 2024 Results
The PRIMO initiative aims to monitor and prevent antibiotic resistance and healthcare-associated infections in community care settings and the medical-social sector. The 2024 national...
(Updated on )
An organization dedicated to supporting programs
Santé publique France is headed by a Director General, appointed by order of the Minister of Health and Prevention, and is assisted by a Deputy Director, a Scientific Director, and a Chief of Staff.
- regional bulletin
Health Monitoring in Mayotte. Bulletin of April 24, 2026.
Key PointsChikungunya81 cases of chikungunya were reported in Week 16 in Mayotte, representing a 28.3% decrease compared to Week 15 (113 cases) (unconsolidated data), with the virus...
- regional bulletin
Health Surveillance in Brittany. Bulletin of April 24, 2026.
Key pointsGastroenteritisModerate activity. Decrease in emergency room visits and SOS Médecins consultations across all age groups.AsthmaModerate activity. Decrease in emergency room...
- regional bulletin
Health Monitoring in Réunion. Bulletin of April 24, 2026.
Key pointsSmallpox B (Mpox)8 cases (including 4 imported cases) were reported in Réunion between S05 and S13/2026.LeptospirosisThe ongoing seasonal resurgence of leptospirosis continues...
- article
(Updated on )
Surveillance of markers for HIV, HTLV, and hepatitis B and C virus infection among blood donors in France from 1991 to 2000
- article
(Updated on )
AIDS Surveillance in Europe, June 30, 1989. Screening of blood donations
- article
(Updated on )
Residual risk of HIV, HCV, and HBV transmission through blood transfusion in France between 1992 and 2002 and the impact of viral genomic testing
The objective of this article is to analyze trends in the residual risk of HIV transmission, HCV, and HBV, over nine three-year periods from 1992–1994 to 1999–2002 and, for HIV and HCV,...
